External broker reports(aggregated public sources), CCZ Statton Equities

CCZ Statton Equities

CCZ is a leading Australian stockbroking firm providing stockbroking and wealth generation services to private clients and institutional investors. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

Kip Mcgrath Education Centres / Equity Bottom-Up

<ul><li>Our last ASX Scheme note argues KME is oversold given long-term opportunity On the balance of probabilities, KME is undervalued.</li><li>While KME’s recent derating has de-risked KME’s returns profile, we understand investors caution given: 1) KME’s inherent operational leverage; 2) deteriorating consumer confidence; and, 3) lack of liquidity, which currently commands a significant discount in micro-caps.</li><li>However, if investors can get comfort (as we have) with KME’s long-term growth and its economic resilience, it could be a multi-bagger.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Our last ASX Scheme note argues KME is oversold given long-term opportunity On the balance of probabilities, KME is undervalued.While KME’s recent derating has de-risked KME’s returns profile, we understand investors caution given: 1) KME’s inherent operational leverage; 2) deteriorating consumer confidence; and, 3) lack of liquidity, which currently commands a significant discount in micro-caps.However, if investors can get comfort (as we have) with KME’s long-term growth and its economic resilience, it could be a multi-bagger.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Kip McGrath - Is There a Price for Your Child’s Future?